University of Thessaly (UTH)
Χαρτογράφηση επιτόπων νοσοειδικών αντιπυρηνικών αντισωμάτων σε ενήλικες και παιδιατρικούς ασθενείς με αυτοάνοσα ρευματικά νοσήματα με έμφαση στη συστηματική σκλήρυνση
Abstract
dc:descriptionThis PhD thesis has studied the epitopes of anti-Ro52 antibodies in patients with systemic sclerosis (SSc). Epitope mapping of anti-Ro52 antibodies has been extensively studied in patients with Sjögren's syndrome (SjS) and systemic lupus erythematosus (SLE). However, no comprehensive epitope mapping study has been performed in patients with systemic sclerosis (SSc), a disease where also the frequency of anti-Ro52 antibodies is increased. Five recombinant fragments of Ro52, covering the full antigen were used to test reactivity using a specifically designed line immunoassay and in house ELISA. In addition, further analysis of the results was performed based on the simultaneous presence or not of anti-Ro60 antibodies. All sera of anti-Ro52 positive patient proved reactive against the Ro52-2 fragment, whereas none against Ro52-3. Antibodies against Ro52-1 were found less frequently in patients with SSc than with SjS and/or SLE. This was also the case, to a lesser extent, against Ro52-4. A particularly interesting finding was the fact that patients with SSc and double anti-Ro52+/anti-Ro60+ reactivity showed greater reactivity against Ro52-1 than anti-Ro52+/anti-Ro60- patients. In this comprehensive analysis of the epitope mapping of Ro52 in SSc, the coiled-coil domain remains the dominant epitope in Ro52. In contrast to SjS and SLE, patients with SSc fail to recognize epitopic regions within the N-terminus of the protein, especially if they lack concomitant Ro60 reactivity. The next step was to study the presence of possible antigen-specific anti-HCMV associations with anti-Ro52 antibodies. Viral agents, such as human cytomegalovirus (HCMV), have been suggested to be the trigger for the onset of SSc. We therefore evaluated the predominant anti-HCMV antibody responses in anti-Ro52 positive and anti-Ro52 negative SSc patients, comparing them with those of SLE and SjS patients. The presence of antibodies against HCMV specific antigens pp130/UL57, pp65/UL83, pp55/UL55, pp52/UL44, p38 and pp28/UL99 was checked by immunoblotting. The main finding of this study was that patients with SSc and positive anti-Ro52 antibodies reacted more frequently against HCMV pp52/UL44 and p38 antigens compared to anti-Ro52(-), an association that was not detected in patients with SLE or SjS. Also, antibody titers against HCMV antigens pp65/UL83, pp52/UL44, and p38 were higher in anti-Ro52(+) than anti-Ro52(−) SSc patients. Therefore, antibody responses against specific HCMV antigens differ between anti-Ro52 positive and negative patients with SSc (as well as between SSc and SLE or SjS), but whether these differences are epiphenomenal remains to be determined. Finally, an epitope mapping study of the B-cell epitopes of anti-Ro52 antibodies in pediatric patients with autoimmune hepatitis (AIH) was performed. The epitope mapping study in anti-Ro52 positive pediatric patients with autoimmune hepatitis was performed using the same specific line immunoassay, mentioned above. The results of this study did not differ from the corresponding results from the epitope mapping study in adult patients with autoimmune diseases. However, the number of patients studied was small, and therefore it is important to perform similar experiments in the future in a larger number of pediatric patients with autoimmune diseases presenting with anti-Ro52 positive antibodies.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gkoutzourelas, Athanasios
- Γκουτζουρέλας, Αθανάσιος
Subjects
dc:subject × 31- Αυτοάνοσα ρευματικά νοσήματα
- Αυτοάνοσα ρευματικά νοσήματα στα παιδιά
- Αυτοαντισώματα
- Αντι-Ro-SSA αντίσωμα
- Συστηματική σκλήρυνση
- Αυτοάνοση ηπατίτιδα (ΑΗ)
- Συστηματικός ερυθηματώδης λύκος ( ΣΕΛ)
- Σύνδρομο Sjogren
- Χαρτογράφηση επιτόπων
- Κυτταρομεγαλοϊός (CMV)
- Μοριακή μίμηση
- Aντισώματα έναντι του HCMV
- Autoimmune diseases
- Pediatric autoimmune diseases
- Anti-Ro/SSA
- Systemic sclerosis
- Systemic lupus erythematosus
- Sjogren's syndrome
- Autoimmune hepatitis
- Epitope mapping
- CMV
- Molecular mimicry
- Anti-HCMV antibodies
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ρευματολογία
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Clinical Medicine
- Medical and Health Sciences
- Rheumatology
- Pediatrics, Perinatology and Child Health
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55901